Wagner Charles F Jr
- SEC CIK
- 0001223348
In the past year, 2 open-market sale filings worth $10.8M and no purchases.
Current role at each company
- TJX TJX Companies IncDirectoras of Jun 11, 2026
- VRTX Vertex Pharmaceuticals IncEVP, CO & FOas of Feb 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $10.8M
- 2 filings
- Net
- −$10.8M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wagner Charles F Jr as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
EVP, CO & FO15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Wagner Charles F JrEVP, CO & FO | SSale | −9.53K | $461.00 | −$4.39M | −20.2%37.7K after | 10b5-1 |
| Dec 5, 2025 (view filing) | Dec 3 | 2 days | Wagner Charles F JrEVP, CO & FO | SSale | −14.0K | $456.00 | −$6.38M | −27.1%37.7K after | 2 lots10b5-1 |
| Mar 12, 2025 (view filing) | Mar 10 | 2 days | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −3.30K | $500.00 | −$1.65M | −6.0%51.7K after | 10b5-1 |
| Nov 13, 2024 (view filing) | Nov 11 | 2 days | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −3.00K | $518.27 | −$1.55M | −6.4%44.1K after | 10b5-1 |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −3.25K | $460.00 | −$1.50M | −6.5%47.1K after | 10b5-1 |
| May 30, 2024 (view filing) | May 28 | 2 days | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −3.25K | $454.79 | −$1.48M | −6.1%50.4K after | 10b5-1 |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −3.00K | $405.00 | −$1.22M | −6.4%43.7K after | 10b5-1 |
| Nov 21, 2023 (view filing) | Nov 20 | 1 day | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −3.00K | $349.88 | −$1.05M | −6.0%46.7K after | 10b5-1 |
| Mar 28, 2023 (view filing) | Mar 24 | 4 days | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −1.77K | $305.38 | −$539.9K | −3.4%49.6K after | 10b5-1 |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Wagner Charles F JrEVP & Chief Financial Officer | SSale | −2.00K | $296.39 | −$592.8K | −3.7%51.4K after | 6 lots10b5-1 |